Log In
Print this Print this

Kogenate FS liposome, NecLip-rFVIII (BAY 79-4980)

Also known as: longer acting kogenate

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionRecombinant Factor VIII (rFVIII) formulated with NecLip liposomes
Molecular Target Factor VIII
Mechanism of ActionProcoagulant
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase III
Standard IndicationHemophilia
Indication DetailsTreat hemophilia
Regulatory Designation
PartnerRecoly N.V.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today